V

Updated Results From the CLEAR Trial: Outcomes of the Combination of Lenvatinib & Pembrolizumab as 1L Therapy in Advanced RCC

By Viktor Grünwald 11 Videos
0 views
April 21, 2023
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
13:37
SIR 2023 Conference Coverage

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

Feat. N. Kothary
29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

15:58
Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

10:19
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implicat…

Feat. K. Mittal
19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

06:58
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very…

Feat. M. Zarba
22:03
Dana-Farber Cancer Institute

RCC Highlights From ASCO® GU 2024

Feat. W. Xu, T. Choueiri
13:46
David McDermott

Overview of a SoC in 1L mRCC Focusing on the Long-Term Survival Data

17:33
Benjamin Garmezy

1L Treatment Approaches in aRCC: Current Data, Treatment Selection, …

06:49
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcin…

Feat. E. Jonasch
15:28
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Bladder and RCC Highlights"

Feat. K. Tawagi, N. Reizine
16:19
OncoAlert

Year in Review: RCC Practice Changing and Practice Informing Trials …

Feat. T. Choueiri
09:54
Insights from 2024 ASCO® GU Annual Meeting

The Impact of Immunotherapy-Based Regimens in Primary Renal Tumors

Feat. R. McKay
09:54
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "1L Systemic Therapy Following Adjuvant IO…

Feat. T. El Zarif
09:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab f…

Feat. B. McGregor
19:30
Natalie Reizine

Recent Advances in Molecular-Guided Treatment of GU Malignancies

15:17
ASCO GU 2023 Conference Coverage

ASCO GU 2023 Systemic Therapy for Recurrent Metastatic RCC: Beyond S…

Feat. T. Zhang